Skip to main content
Alexander Pantelyat, MD, Neurology, Baltimore, MD

Alexander Yuryevich Pantelyat MD

Movement Disorder, Neurophysiology, Neurodegenerative, Dementia & Geriatrics


Associate Professor of Neurology, Johns Hopkins University School of Medicine; Director, Johns Hopkins Atypical Parkinsonism Center; Co-Founder and Director, Johns Hopkins Center for Music & Medicine

Join to View Full Profile
  • 601 North Caroline StreetFloor 5Baltimore, MD 21287

  • Phone+1 410-955-9441

  • Fax+1 410-955-6402

Dr. Pantelyat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Founder and Director, Johns Hopkins Center for Music and Medicine
    Founder and Director, Johns Hopkins Atypical Parkinsonism Center
  • Center for Music & Medicine

    The Center for Music & Medicine treats conditions affecting musicians and performers and explores the therapeutic potential of music in medical care.

Education & Training

  • Philadelphia VA Medical Center/Pennsylvania Hospital
    Philadelphia VA Medical Center/Pennsylvania HospitalMovement Disorders Fellow, 2012 - 2014
  • University of Pennsylvania School of Medicine
    University of Pennsylvania School of MedicineN/A, Biostatistics and Epidemiology Clinical Research Certificate Program, 2012 - 2014
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Neurology, 2009 - 2012
  • Pennsylvania Hospital of the University of Pennsylvania Health System
    Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 2008 - 2009
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2008

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2014 - 2027
  • PA State Medical License
    PA State Medical License 2008 - 2014
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015-2017
  • CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017
  • CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2015-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Poly(ADP-Ribose) Drives Pathologic Α-synuclein Neurodegeneration in Parkinson’s Disease  
    James B Leverenz, Ted M Dawson, Alexander Pantelyat, Liana S Rosenthal, Juan C Troncoso, Science Magazine

Books/Book Chapters

Abstracts/Posters

  • Hyposmia and other non-motor symptoms are associated with persistent drug-induced Parkinsonism.
    Pantelyat A, Pawlowski S, Kesari A, Maina I, Duda, J, Morley J, the17th International Congress of Parkinson’s Disease and Movement Disorders
  • Quantitative assessment of bradykinesia in Parkinson's disease.
    Pantelyat A, Freedman R, Pawlowski S, Kesari A, Duda J, Morley J, the 65th Annual Meeting of the American Academy of Neurology
  • Acalculia in autopsy-proven corticobasal degeneration.
    Pantelyat A, Dreyfuss M, Moore, P, Gross, R, Schuck T, Irwin D,Trojanowski J, Grossman M, the 2010 Annual Meeting of the Pennsylvania Neurological Society

Other

  • AAN Practice Guideline on the initiation of treatment for newly diagnosed Parkinson’s disease. 
    Miyasaki J, Gronseth G, Martin W, et al
  • Introduction to Movement Disorders. 
    Pantelyat A, University of Pennsylvania medical students as part of their Neurology Clerkship
  • Music and Dance Therapy for Parkinson’s Disease. 
    Pantelyat A, Patients and their families at Pennsylvania Hospital

Press Mentions

  • Blood Test Detects ALS Years Before Symptom Onset
    Blood Test Detects ALS Years Before Symptom OnsetSeptember 4th, 2025
  • Investigational Blood Test Detects ALS up to 10 Years Before Symptoms Appear
    Investigational Blood Test Detects ALS up to 10 Years Before Symptoms AppearSeptember 2nd, 2025
  • Blood Test Able to Detect ALS up to a Decade Before Symptoms Start
    Blood Test Able to Detect ALS up to a Decade Before Symptoms StartAugust 28th, 2025

Grant Support

  • Digital Health Technologies for Monitoring Motor Function in Progressive Supranuclear Palsy and Dementia with Lewy BodiesBIOSENSICS, LLC2025–2029
  • A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration SyndromesBIOSENSICS, LLC2022–2025
  • A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration SyndromesBIOSENSICS, LLC2022–2025
  • BIOMARKER DISCOVERY AND VALIDATION IN PSPJOHNS HOPKINS UNIVERSITY2018–2025

Professional Memberships

Other Languages

  • Russian, Spanish, Ukrainian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: